Phare Operating System (Phare OS)
R1 RCM · Hospitals and health systems (enterprise) · Cloud SaaS with managed services
Revenue Cycle / Coding / Prior Auth
Enterprise agentic AI platform spanning the full revenue cycle via three flagship products: Phare Access (patient access and authorization), Phare Claim (autonomous inpatient coding/CDI), and Phare Flow (autonomous claim follow-up, denials, and appeals). R1 reports Phare Claim autonomous coding accuracy as high as 97% for select service lines and Phare Flow already automating more than 20% of payer documentation requests by dollar volume.
Evidence at a glance
Freshness, source-checked counts, confidence and gate results below reflect the frozen evidence snapshot through . A later editorial review does not update these results.
- Stated intended users
- CFOs and revenue cycle leaders at hospitals and large health systems (R1 serves 95 of the top 100 U.S. health systems)
- Documentary gate at snapshot
- Failed
- Scenario match
- Outside this scenario — Prior-auth automation under CMS-0057-F
- Comparability
- Not yet comparable in this scenario
- Decision readiness at snapshot
- HISTORICAL — Research only
- Documented evidence at snapshot
- 3 of 5 evidence claims source-checked · confidence Low
- Critical unknowns
- scaled production deployment · documented economic outcomes
- Latest checked-source retrieval in snapshot
- 2026-08-27
Expand each claim to inspect its source, dates and recorded verification status.
press releaseR1 launched the Phare Operating System, healthcare's first Revenue Operating System, with Phare Claim delivering autonomous coding accuracy …2025-10-22
Exact claim. R1 launched the Phare Operating System, healthcare's first Revenue Operating System, with Phare Claim delivering autonomous coding accuracy as high as 97% and Phare Flow automating over 20% of payer documentation requests by dollar volume; the platform is integrated across all major EMRs with connections to 1,000+ payers and visibility into 670M+ annual patient encounters.
- Source
- r1rcm.com
- Type
- press release
- Published
- 2025-10-22
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- deployment_traction
Vendor or press announcement. Verify material claims against primary filings or contracts.
Open r1rcm.compress releaseR1 press release (Oct 22, 2025) launching Phare OS: Phare Claim is delivering autonomous coding accuracy rates as high as 97% for service li…2025-10-22
Exact claim. R1 press release (Oct 22, 2025) launching Phare OS: Phare Claim is delivering autonomous coding accuracy rates as high as 97% for service lines like emergency room and physician office visits and over 30% inpatient coding automation; Phare Flow's agentic workflows already fully automate over 20% of payer documentation requests by dollar volume and were expected to deliver agentic coverage on almost 40% of denied dollars by end of 2025.
- Source
- r1rcm.com
- Type
- press release
- Published
- 2025-10-22
- Retrieved
- 2026-08-27
- Verification
- excerpt_matched
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- economic_value
Vendor or press announcement. Verify material claims against primary filings or contracts.
Open r1rcm.compress releaseR1 agreed to acquire Phare Health, an AI-native inpatient coding and CDI platform, extending R1's agentic AI capabilities after its R37 AI l…2025-10-14
Exact claim. R1 agreed to acquire Phare Health, an AI-native inpatient coding and CDI platform, extending R1's agentic AI capabilities after its R37 AI lab put agentic applications in production with select clients.
- Source
- r1rcm.com
- Type
- press release
- Published
- 2025-10-14
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- market_durability
- Score contribution
- Feeds market durability
Vendor or press announcement. Verify material claims against primary filings or contracts.
Open r1rcm.compress releaseR1 launched R37, an AI lab in exclusive partnership with Palantir, to deploy comprehensive agentic RCM worker solutions to enterprise custom…2025-03-14
Exact claim. R1 launched R37, an AI lab in exclusive partnership with Palantir, to deploy comprehensive agentic RCM worker solutions to enterprise customers.
- Source
- r1rcm.com
- Type
- press release
- Published
- 2025-03-14
- Retrieved
- 2026-08-27
- Verification
- excerpt_matched
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- general
Vendor or press announcement. Verify material claims against primary filings or contracts.
Open r1rcm.compress releaseTowerBrook Capital Partners and Clayton, Dubilier & Rice completed their acquisition of R1 at $14.30/share in cash, valuing the company at a…2024-11-19
Exact claim. TowerBrook Capital Partners and Clayton, Dubilier & Rice completed their acquisition of R1 at $14.30/share in cash, valuing the company at approximately $8.9 billion and taking it private.
- Source
- r1rcm.com
- Type
- press release
- Published
- 2024-11-19
- Retrieved
- 2026-08-27
- Verification
- excerpt_matched
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- market_durability
- Score contribution
- Feeds market durability
Vendor or press announcement. Verify material claims against primary filings or contracts.
Open r1rcm.comVerified provider experience is not yet publishable. Fewer than five independent provider organizations have contributed eligible reviews. Reviewer mode is off. Experience never changes documentary scoring, freshness, or rank.
Buyer lenses — evidence-backed bands at snapshot (not a 0–100 rank)
Deployment, integration, data handling at snapshot
- Integration maturity
- announced — Announced or documented integration; marketplace listing not confirmed.
- EHR path
- All major EMRs
- FHIR / API
- UNKNOWN
Why unknown
Why. No reliable source on file. The platform does not infer values from weak sources.
What would close it. A primary source or independent verification.
- SSO
- UNKNOWN
Why unknown
Why. Single-sign-on support is not documented in vendor or marketplace materials on file.
What would close it. Vendor security documentation or marketplace listing mentioning SSO/SAML/OIDC.
- PHI / BAA
- PHI processed in-scope; HIPAA-compliant with HIPAA-compliant Business Associate Agreements (per SEC 10-K cybersecurity disclosure) · BAA available
- Security attestations
- SOC 2 Type 2, HITRUST CSF, PCI DSS
- FDA status
- UNKNOWN
Why unknown
Why. No FDA listing found for this product's functions in the tracked category.
What would close it. An FDA 510(k)/De Novo listing, or a clear statement that no regulated function is claimed.
- Pricing
- Not publicly listed
Technical provenance
snap_36bba25c577cbb44 · Evidence cutoff: 2026-08-27T04:05Z · Snapshot generated: 2026-10-21T19:39Z · build ffbf5c3
Forecast calibration is not in the public snapshot — shown as UNKNOWN rather than read from SQLite.
Known limitations
- Deployment traction is UNKNOWN.
Why unknown
Why. No reliable source on file. The platform does not infer values from weak sources.
What would close it. A primary source or independent verification.
- Economic value evidence is UNKNOWN.
Why unknown
Why. No independently verifiable ROI claim (peer-reviewed, audited case, or independent benchmark) is on file.
What would close it. An audited implementation report or peer-reviewed study with payback/throughput numbers.